Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Leonard

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Cytotherapy|March 20, 2024
Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse modelsSelami Demirci, Muhammad B N Khan, Gabriela Hinojosa, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Molecular Therapy. Nucleic Acids|February 28, 2023
Forced enhancer-promoter rewiring to alter gene expression in animal modelsScott A Peslak, Selami Demirci, Vemika Chandra, et al.
The Journal of Clinical Investigation|September 8, 2020
BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, Jing Zeng, Yuxuan Wu, et al.
Cell Stem Cell|December 6, 2024
BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugateSelami Demirci, Jing Zeng, Rahul Palchaudhuri, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.
Cytotherapy|March 20, 2024
Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse modelsSelami Demirci, Muhammad B N Khan, Gabriela Hinojosa, et al.
Cell Reports. Medicine|May 5, 2021
Preclinical evaluation for engraftment of CD34<sup>+</sup> cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate modelsNaoya Uchida, Linhong Li, Tina Nassehi, et al.
Molecular Therapy. Nucleic Acids|February 28, 2023
Forced enhancer-promoter rewiring to alter gene expression in animal modelsScott A Peslak, Selami Demirci, Vemika Chandra, et al.
The Journal of Clinical Investigation|September 8, 2020
BCL11A enhancer-edited hematopoietic stem cells persist in rhesus monkeys without toxicitySelami Demirci, Jing Zeng, Yuxuan Wu, et al.
Cell Stem Cell|December 6, 2024
BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugateSelami Demirci, Jing Zeng, Rahul Palchaudhuri, et al.
Pageof 4